Neuroblox
PrivateLast Round
Accelerator
Feb 24, 2025
Total Funding Raised
$3.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neuroblox operates in Healthcare & Life Sciences and is based in Stony Brook, New York. Its latest recorded funding round was an Accelerator round in February 2025.
Neuroblox is a biotechnology and software company that provides a multiscale, mechanistic neural circuit simulation platform for designing and testing neurotherapeutics in silico.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuroblox Comparables
Compare Neuroblox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Forecast Bio, Inc. | 81% | |
| InSilicoTrials Technologies | 77% | |
| NeuroX1 | 75% |
For institutional investors. Book with your work email.
Neuroblox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 24, 2025 | ||||
| Grant | May 8, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neuroblox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baszucki Group | Grant |
| One Mind Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 39% MoM, reaching 3.1K.
- Jul 27, 2026
Monthly visitors increased 1235% MoM.
For institutional investors. Book with your work email.
Neuroblox Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuroblox's valuation, stock price, and market status.
Is Neuroblox a public or private company?
Neuroblox is a private company.
What is the current stock price of Neuroblox?
Neuroblox is a private company, so its shares have no public market price. Caplight tracks Neuroblox's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuroblox worth (valuation)?
Valuation information for Neuroblox is not publicly available.
Can I buy Neuroblox stock?
Neuroblox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuroblox's last funding round?
Neuroblox's most recent funding round was Accelerator on February 24, 2025.
Who are the main investors in Neuroblox?
Key investors in Neuroblox include Baszucki Group.
Will Neuroblox IPO soon?
No public IPO plans have been announced for Neuroblox.
How can I track Neuroblox secondary market activity?
Caplight tracks bids, offers, and trades in Neuroblox's shares on secondary markets.